Article
Effectiveness of antiepileptic therapy in patients with PCDH19 mutations.
Seizure - 1 Feb 2016
Lotte Jan, Bast Thomas, Borusiak Peter, Coppola Antonietta, Cross J Helen, Dimova Petia, Fogarasi Andras, Graneß Irene, Guerrini Renzo, Hjalgrim Helle, Keimer Reinhard, Korff Christian M, Kurlemann Gerhard, Leiz Steffen, Linder-Lucht Michaela, Loddenkemper Tobias, Makowski Christine, Mühe Christian, Nicolai Joost, Nikanorova Marina, Pellacani Simona, Philip Sunny, Ruf Susanne, Sánchez Fernández Iván, Schlachter Kurt, Striano Pasquale, Sukhudyan Biayna, Valcheva Deyana, Vermeulen R Jeroen, Weisbrod Tanja, Wilken Bernd, Wolf Philipp, Kluger Gerhard
Abstract excerpt
PURPOSE: PCDH19 mutations cause epilepsy and mental retardation limited to females (EFMR) or Dravet-like syndromes. Especially in the first years of life, epilepsy is known to be highly pharmacoresistant. The aim of our study was to evaluate the effectiveness of antiepileptic therapy in patients with PCDH19 mutations. METHODS: We report a retrospective multicenter study of antiepileptic therapy in 58 female...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
